SBC Medical Group Holdings Incorporated (SBC) Income Statement
SBC 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsSBC revenue and net income
Where SBC's revenue goes
2025Each bar shows an amount and its share of revenue. SBC kept 29.4% of revenue as net income.
SBC profit margins
SBC growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −15.5% | −0.1% | — | — |
| Gross profit | −18.4% | +3.5% | — | — |
| Operating income | −4.0% | +49.7% | — | — |
| Net income | +9.4% | +100.6% | — | — |
| EPS (diluted) | −79.3% | +130.5% | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
SBC quarterly EPS vs estimates
SBC Medical beat the analyst EPS estimate in 4 of the last 8 quarters. Next report: November 13, 2026 (estimate $0.11).
SBC income statement
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $173.6M | $205.4M | $193.5M | $174.2M |
| Cost of revenue | $46.3M | $49.4M | $56.2M | $59.3M |
| Gross profit | $127.3M | $156.1M | $137.3M | $114.8M |
| Sales, general & admin | $58.9M | $70.1M | $66.2M | $93.5M |
| Total operating expenses | $59.8M | $85.7M | $66.6M | $94.7M |
| Operating income | $67.5M | $70.3M | $70.7M | $20.1M |
| Interest income | $198,315 | $19,943 | $86,748 | $472,382 |
| Interest expense | $160,583 | $28,300 | $45,292 | $31,441 |
| Income before taxes | $82.1M | $73.5M | $73.6M | $23.7M |
| Income taxes | $31.0M | $26.8M | $35.0M | $18.1M |
| Net income | $51.0M | $46.6M | $39.4M | $6.3M |
| EBITDA | $84.9M | $77.3M | $85.9M | $29.6M |
| EPS (diluted) | $0.49 | $2.37 | $0.00 | $0.04 |
| Gross margin | 73.3% | 76.0% | 70.9% | 65.9% |
| Operating margin | 38.9% | 34.2% | 36.5% | 11.6% |
| Net margin | 29.4% | 22.7% | 20.3% | 3.6% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $49.2M | $43.1M | $39.6M | $43.4M | $43.4M | $47.3M | $44.4M | $53.1M | $53.1M | $54.8M | $62.3M | $47.3M |
| Cost of revenue | $13.2M | $13.0M | $10.6M | $13.5M | $13.3M | $9.6M | $10.5M | $9.8M | $13.7M | $15.3M | $19.0M | $13.8M |
| Gross profit | $36.0M | $30.0M | $28.9M | $29.9M | $30.0M | $37.7M | $33.9M | $43.2M | $39.4M | $39.5M | $43.4M | $33.5M |
| Sales, general & admin | $17.0M | $12.2M | $20.6M | $13.9M | $14.4M | $12.8M | $13.9M | $29.3M | $11.8M | $15.0M | $19.3M | $13.4M |
| Total operating expenses | $17.0M | $12.3M | $16.1M | $14.0M | $15.5M | $13.5M | $29.2M | $29.4M | $12.1M | $15.1M | $19.4M | $13.5M |
| Operating income | $19.0M | $17.7M | $12.8M | $15.9M | $14.6M | $24.2M | $4.7M | $13.8M | $27.3M | $24.5M | $24.0M | $20.0M |
| Interest income | $8,520 | $121,369 | $284 | $120,384 | $22,882 | $55,333 | $17,340 | $7,950 | $11,644 | $17,689 | $403 | $10,234 |
| Interest expense | $128,629 | $114,806 | $56,090 | $48,635 | $49,651 | $6,207 | $12,402 | $5,466 | $7,424 | $3,008 | $7,912 | $3,978 |
| Income before taxes | $19.6M | $18.9M | $18.6M | $18.5M | $13.5M | $31.5M | $6.1M | $13.1M | $27.1M | $27.2M | $23.6M | $21.1M |
| Income taxes | $7.8M | $7.5M | $4.3M | $5.7M | $11.1M | $10.0M | −$488,553 | $10.3M | $8.5M | $8.5M | $9.3M | $13.0M |
| Net income | $10.7M | $11.3M | $14.2M | $12.8M | $2.5M | $21.5M | $6.5M | $2.8M | $18.5M | $18.8M | $14.3M | $8.4M |
| EBITDA | $19.4M | $19.6M | $19.3M | $19.3M | $14.2M | $32.1M | $7.0M | $14.1M | $27.9M | $28.2M | $26.1M | $24.4M |
| EPS (diluted) | $0.10 | $0.11 | $0.14 | $0.12 | $0.02 | $0.21 | $0.06 | $0.03 | $2.33 | −$0.05 | −$0.04 | −$0.02 |
| Gross margin | 73.1% | 69.8% | 73.1% | 69.0% | 69.2% | 79.7% | 76.3% | 81.5% | 74.2% | 72.1% | 69.6% | 70.9% |
| Operating margin | 38.5% | 41.2% | 32.5% | 36.6% | 33.6% | 51.1% | 10.6% | 26.1% | 51.4% | 44.6% | 38.5% | 42.4% |
| Net margin | 21.7% | 26.3% | 35.9% | 29.6% | 5.7% | 45.4% | 14.7% | 5.3% | 34.8% | 34.2% | 23.0% | 17.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in SBC's financial statements (latest annual report filed March 27, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
SBC financial results
In fiscal year 2025 (ended December 31, 2025), SBC Medical reported revenue of $173.6 million, down 15.5% from the year before. It had net income of $51.0 million (up 9.4%), a net profit margin of 29.4%. Diluted earnings per share came to $0.49.
See the SBC stock overview for the latest quote and news, or the SBC chart for price history and technical indicators.
SBC income statement FAQ
What is SBC Medical's annual revenue?
SBC Medical reported total revenue of $173.6 million for fiscal year 2025, which ended on December 31, 2025. That was down 15.5% from $205.4 million the previous year.
Is SBC Medical profitable?
Yes. SBC Medical reported net income of $51.0 million in fiscal 2025, a net profit margin of 29.4%; its operating margin was 38.9%.
What is SBC Medical's gross margin?
SBC Medical's gross margin was 73.3% in fiscal 2025: for every $100 of revenue, SBC Medical kept $73 after the direct cost of its products and services.
What are SBC Medical's earnings per share?
SBC Medical earned $0.49 per diluted share in fiscal 2025, compared with $2.37 a year earlier.
When will SBC Medical report its next earnings?
SBC Medical is expected to report results for the quarter ending September 30, 2026 on November 13, 2026 before the market opens.
When does SBC Medical's fiscal year end?
SBC Medical's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 27, 2026.